Market Tracker

04/24 6:02pm ET

Incyte Corp (NASDAQ:INCY)

107.34
Delayed Data
As of Apr 24
 -0.51 / -0.47%
Today’s Change
43.44
Today|||52-Week Range
111.93
+46.82%
Year-to-Date

Today’s Trading

Previous close107.85
Today’s open107.59
Day’s range106.75 - 108.55
Volume854,645
Average volume (3 months)1,194,764
Market cap$18.7B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+13.58%
Earnings growth (next 5 years)+209.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-2.67-2.17%
PCYCPharmacyclics Inc-0.51-0.20%
ENDPEndo International P...-0.81-0.86%
HSPHospira Inc-0.05-0.06%
Data as of 4:01pm ET, 04/24/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts